Skip to content
OpenCapital
Get started

Wave Life Sciences WVE EBITDA

EBITDA at other companies

ALN
Alnylam PharmaceuticalsALNY
$282.19M+769%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$101.61M+10.7%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$124.73M-2.3%
Eli Lilly logo
Eli LillyLLY
——
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
——
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
——

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%—
Debt / equity0×-0.1×
Current ratio11.3×+8.3×

Where this comes from

Calculated from Wave Life Sciences’s reported figures.

−$31.3Mebit+
$841.0KDepreciation Depletion & Amortization
=-$30.46M

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's EBITDA?
Wave Life Sciences (WVE) reported EBITDA of -$30.46M in Q1 2026.
How has Wave Life Sciences's EBITDA changed year-over-year?
Wave Life Sciences's EBITDA increased by 37.8% year-over-year, from -$48.93M to -$30.46M.
What is the long-term trend for Wave Life Sciences's EBITDA?
Over 3 years (2021 to 2025), Wave Life Sciences's EBITDA has grown at a 21.0% compound annual growth rate (CAGR), from -$119.53M to -$211.94M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.